Friday, January 18, 2013

Just Released: IIR's Medical Device Pricing, Reimbursement and Market Access Forum Agenda

A substantial setback to higher profitability and success for medical devices is the ambiguity of how to demonstrate value to potential customers. With the shift to an evidence-based value proposition, device manufacturers are seeking clarity for how to sell their products in this new environment. The all new Medical Device Pricing, Reimbursement and Market Access Forum brings together leaders across the commercialization value-chain to answer the reimbursement questions challenging the success of your product.

Get exclusive multi-stakeholder perspectives on how to overcome reimbursement challenges for market success:
  • ● Health Plan Keynote: Michael Sherman, MD, an d Senior Vice President and Chief Medical Officer, HARVARD PILGRIM HEALTH CARE
  • ● Government Keynote: David Seltz, Special Advisor, Health Care Cost Containment Office, OFFICE OF THE GOVERNOR OF MASSACHUSETTS
  • ● Provider Perspective: Lawrence Schecter, MD, Chief Medical Officer, WASHINGTON REGIONAL PROVIDENCE HEALTH & SERVICES
  • ● State Technology Assessment: Josh Morse, Program Director, WASHINGTON HEALTH TECHNOLOGY ASSESSMENT PROGRAM
  • ● Device Manufacturer: Robert Giffin, Vice President, Healthcare Policy and Reimbursement, COVIDIEN

This will also be located with the 2nd Annual Future of Companion Diagnostics Commercialization Summit! As a reader of this blog, when you register to join us in Boston this May 22-23, 2013 and mention code XP1813BLOG, you’ll save 15% off the standard rate. If you have any questions about this event, feel free to email Jennifer Pereira.

No comments: